 | Up a level |
Scobioala, Sergiu; Parfitt, Ross; Matulat, Peter; Byrne, Julianne; Langer, Thorsten; Troschel, Fabian M; Hesping, Amélie E; Clemens, Eva; Kaatsch, Peter; Grabow, Desiree; Kaiser, Melanie; Spix, Claudia; Kremer, Leontien C; Calaminus, Gabriele; Baust, Katja; Kuehni, Claudia E; Weiss, Annette; Strebel, Sven; Kuonen, Rahel; Elsner, Susanne; ... (2024). The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium. International journal of cancer, 154(2), pp. 320-331. Wiley 10.1002/ijc.34732
Lohr, Frank; Georg, Dietmar; Cozzi, Luca; Eich, Hans Theodor; Weber, Damien Charles; Koeck, Julia; Knäusl, Barbara; Dieckmann, Karin; Abo-Madyan, Yasser; Fiandra, Christian; Mueller, Rolf-Peter; Engert, Andreas; Ricardi, Umberto (2014). Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open? Strahlentherapie und Onkologie, 190(10), pp. 864-871. Springer-Medizin-Verlag 10.1007/s00066-014-0719-9
Eich, Hans Theodor; Diehl, Volker; Görgen, Helen; Pabst, Thomas; Markova, Jana; Debus, Jürgen; Ho, Anthony; Dörken, Bernd; Rank, Andreas; Grosu, Anca-Ligia; Wiegel, Thomas; Karstens, Johann Hinrich; Greil, Richard; Willich, Normann; Schmidberger, Heinz; Döhner, Hartmut; Borchmann, Peter; Müller-Hermelink, Hans-Konrad; Müller, Rolf-Peter and Engert, Andreas (2010). Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. Journal of clinical oncology, 28(27), pp. 4199-206. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.29.8018
